ticlopidine has been researched along with Transfusion Reaction in 4 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Transfusion Reaction: Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility.
Excerpt | Relevance | Reference |
---|---|---|
"Oral reversible platelet P2Y12 receptor inhibitors (ticagrelor and elinogrel) cause double-digit rates of dyspnea, while irreversible oral antiplatelet drugs (aspirin, ticlopidoine, clopidogrel, and prasugrel) or intravenous glycoprotein IIb/IIIa inhibitors (abciximab, eptifibatide, or tirofiban) do not increase the incidence of dyspnea in randomized trials." | 8.90 | Dyspnea and reversibility of antiplatelet agents: ticagrelor, elinogrel, cangrelor, and beyond. ( DiNicolantonio, JJ; Serebruany, VL; Sibbing, D, 2014) |
"Oral reversible platelet P2Y12 receptor inhibitors (ticagrelor and elinogrel) cause double-digit rates of dyspnea, while irreversible oral antiplatelet drugs (aspirin, ticlopidoine, clopidogrel, and prasugrel) or intravenous glycoprotein IIb/IIIa inhibitors (abciximab, eptifibatide, or tirofiban) do not increase the incidence of dyspnea in randomized trials." | 4.90 | Dyspnea and reversibility of antiplatelet agents: ticagrelor, elinogrel, cangrelor, and beyond. ( DiNicolantonio, JJ; Serebruany, VL; Sibbing, D, 2014) |
"We performed a retrospective cohort study of 1677 patients undergoing coronary artery bypass surgery to determine the relationship of the preoperative use of aspirin plus clopidogrel vs aspirin alone to the 30-day incidence of postoperative surgical site infection and bacteremia." | 3.75 | Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery. ( Alejo, D; Baumgartner, WA; Blasco-Colmenares, E; Conte, JV; Faraday, N; Guallar, E; Pastor-Barriuso, R; Perl, TM; Sharrett, AR, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Rosengart, TK | 1 |
Romeiser, JL | 1 |
White, LJ | 1 |
Fratello, A | 1 |
Fallon, E | 1 |
Senzel, L | 1 |
Shroyer, AL | 1 |
Serebruany, VL | 1 |
Sibbing, D | 1 |
DiNicolantonio, JJ | 1 |
Jones, DW | 1 |
Schermerhorn, ML | 1 |
Brooke, BS | 1 |
Conrad, MF | 1 |
Goodney, PP | 1 |
Wyers, MC | 1 |
Stone, DH | 1 |
Blasco-Colmenares, E | 1 |
Perl, TM | 1 |
Guallar, E | 1 |
Baumgartner, WA | 1 |
Conte, JV | 1 |
Alejo, D | 1 |
Pastor-Barriuso, R | 1 |
Sharrett, AR | 1 |
Faraday, N | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Alignment of Treatment Preferences and Repair Type for Veterans With AAA[NCT03115346] | 238 participants (Anticipated) | Interventional | 2017-04-15 | Active, not recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for ticlopidine and Transfusion Reaction
Article | Year |
---|---|
Dyspnea and reversibility of antiplatelet agents: ticagrelor, elinogrel, cangrelor, and beyond.
Topics: Acute Lung Injury; Adenosine; Adenosine Monophosphate; Administration, Oral; Clopidogrel; Dyspnea; H | 2014 |
3 other studies available for ticlopidine and Transfusion Reaction
Article | Year |
---|---|
Platelet activity measured by a rapid turnaround assay identifies coronary artery bypass grafting patients at increased risk for bleeding and transfusion complications after clopidogrel administration.
Topics: Aged; Blood Platelets; Chi-Square Distribution; Clopidogrel; Coronary Artery Bypass; Decision Suppor | 2013 |
Perioperative clopidogrel is associated with increased bleeding and blood transfusion at the time of lower extremity bypass.
Topics: Aged; Blood Loss, Surgical; Blood Transfusion; Chi-Square Distribution; Clopidogrel; Databases, Fact | 2017 |
Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery.
Topics: Aged; Aspirin; Bacteremia; Blood Transfusion; Clopidogrel; Cohort Studies; Coronary Artery Bypass; D | 2009 |